{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T03:15:04Z","timestamp":1783566904712,"version":"3.55.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T00:00:00Z","timestamp":1783555200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T00:00:00Z","timestamp":1783555200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the National Natural Science Foundation of China General Program","award":["32471036"],"award-info":[{"award-number":["32471036"]}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82303822"],"award-info":[{"award-number":["82303822"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Funct Integr Genomics"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s10142-026-01973-2","type":"journal-article","created":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T02:43:02Z","timestamp":1783564982000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Integrative bulk and single-cell analyses implicate ASL in MIF-associated myeloid programs in glioblastoma"],"prefix":"10.1007","volume":"26","author":[{"given":"Wenjing","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shenglan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7638-4395","authenticated-orcid":false,"given":"Wenbin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,9]]},"reference":[{"issue":"12","key":"1973_CR1","doi-asserted-by":"publisher","first-page":"2628","DOI":"10.1016\/j.cell.2023.05.013","volume":"186","author":"M Arora","year":"2023","unstructured":"Arora M et al (2023) Rapid adaptation to CDK2 inhibition exposes intrinsic cell-cycle plasticity. Cell 186(12):2628-2643 e21. https:\/\/doi.org\/10.1016\/j.cell.2023.05.013","journal-title":"Cell"},{"key":"1973_CR2","doi-asserted-by":"publisher","DOI":"10.3390\/biom11081086","author":"I Bednarz-Misa","year":"2021","unstructured":"Bednarz-Misa I et al (2021) Altered L-arginine metabolic pathways in gastric cancer: potential therapeutic targets and biomarkers. Biomolecules. https:\/\/doi.org\/10.3390\/biom11081086","journal-title":"Biomolecules"},{"issue":"1","key":"1973_CR3","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s40478-021-01156-z","volume":"9","author":"A Buonfiglioli","year":"2021","unstructured":"Buonfiglioli A, Hambardzumyan D (2021) Macrophages and microglia: the cerberus of glioblastoma. Acta Neuropathol Commun 9(1):54. https:\/\/doi.org\/10.1186\/s40478-021-01156-z","journal-title":"Acta Neuropathol Commun"},{"issue":"6","key":"1973_CR4","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.tips.2015.03.006","volume":"36","author":"RB Caldwell","year":"2015","unstructured":"Caldwell RB et al (2015) Arginase: an old enzyme with new tricks. Trends Pharmacol Sci 36(6):395\u2013405. https:\/\/doi.org\/10.1016\/j.tips.2015.03.006","journal-title":"Trends Pharmacol Sci"},{"key":"1973_CR5","doi-asserted-by":"publisher","unstructured":"Cancer Genome Atlas Research N. et al. (2015) Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas. N Engl J Med 372(26): 2481\u201398.https:\/\/doi.org\/10.1056\/NEJMoa1402121","DOI":"10.1056\/NEJMoa1402121"},{"key":"1973_CR6","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01004","volume":"9","author":"Z Chen","year":"2018","unstructured":"Chen Z, Hambardzumyan D (2018) Immune microenvironment in glioblastoma subtypes. Front Immunol 9:1004. https:\/\/doi.org\/10.3389\/fimmu.2018.01004","journal-title":"Front Immunol"},{"issue":"10","key":"1973_CR7","doi-asserted-by":"publisher","first-page":"2148","DOI":"10.1002\/glia.23883","volume":"68","author":"Z Chen","year":"2020","unstructured":"Chen Z et al (2020) Genetic driver mutations introduced in identical cell-of-origin in murine glioblastoma reveal distinct immune landscapes but similar response to checkpoint blockade. Glia 68(10):2148\u20132166. https:\/\/doi.org\/10.1002\/glia.23883","journal-title":"Glia"},{"issue":"1","key":"1973_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-37361-8","volume":"14","author":"Z Chen","year":"2023","unstructured":"Chen Z et al (2023) Monocyte depletion enhances neutrophil influx and proneural to mesenchymal transition in glioblastoma. Nat Commun 14(1):1839. https:\/\/doi.org\/10.1038\/s41467-023-37361-8","journal-title":"Nat Commun"},{"issue":"22","key":"1973_CR9","doi-asserted-by":"publisher","first-page":"5878","DOI":"10.1158\/0008-5472.CAN-12-1572-T","volume":"72","author":"P Chinnaiyan","year":"2012","unstructured":"Chinnaiyan P et al (2012) The metabolomic signature of malignant glioma reflects accelerated anabolic metabolism. Cancer Res 72(22):5878\u201388. https:\/\/doi.org\/10.1158\/0008-5472.CAN-12-1572-T","journal-title":"Cancer Res"},{"issue":"8","key":"1973_CR10","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1056\/NEJMoa1308345","volume":"370","author":"OL Chinot","year":"2014","unstructured":"Chinot OL et al (2014) Bevacizumab plus radiotherapy-temozolomide for newly diagnosed glioblastoma. N Engl J Med 370(8):709\u201322. https:\/\/doi.org\/10.1056\/NEJMoa1308345","journal-title":"N Engl J Med"},{"issue":"10","key":"1973_CR11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0074798","volume":"8","author":"PH Domingues","year":"2013","unstructured":"Domingues PH et al (2013) Association between inflammatory infiltrates and isolated monosomy 22\/del(22q) in meningiomas. PLoS ONE 8(10):e74798. https:\/\/doi.org\/10.1371\/journal.pone.0074798","journal-title":"PLoS ONE"},{"issue":"7","key":"1973_CR12","doi-asserted-by":"publisher","first-page":"1922","DOI":"10.1128\/MCB.01907-08","volume":"29","author":"G Fingerle-Rowson","year":"2009","unstructured":"Fingerle-Rowson G et al (2009) A tautomerase-null macrophage migration-inhibitory factor (MIF) gene knock-in mouse model reveals that protein interactions and not enzymatic activity mediate MIF-dependent growth regulation. Mol Cell Biol 29(7):1922\u201332. https:\/\/doi.org\/10.1128\/MCB.01907-08","journal-title":"Mol Cell Biol"},{"key":"1973_CR13","doi-asserted-by":"publisher","DOI":"10.1172\/JCI163451","author":"D Friedmann-Morvinski","year":"2023","unstructured":"Friedmann-Morvinski D, Hambardzumyan D (2023) Monocyte-neutrophil entanglement in glioblastoma. J Clin Invest. https:\/\/doi.org\/10.1172\/JCI163451","journal-title":"J Clin Invest"},{"issue":"1","key":"1973_CR14","first-page":"8","volume":"2","author":"RJ Haines","year":"2011","unstructured":"Haines RJ, Pendleton LC, Eichler DC (2011) Argininosuccinate synthase: at the center of arginine metabolism. Int J Biochem Mol Biol 2(1):8\u201323","journal-title":"Int J Biochem Mol Biol"},{"issue":"6","key":"1973_CR15","doi-asserted-by":"publisher","first-page":"e142137","DOI":"10.1172\/JCI142137","volume":"132","author":"N Hajji","year":"2022","unstructured":"Hajji N et al (2022) Arginine deprivation alters microglial polarity and synergizes with radiation to eradicate non-arginine-auxotrophic glioblastoma tumors. J Clin Invest 132(6):e142137. https:\/\/doi.org\/10.1172\/JCI142137","journal-title":"J Clin Invest"},{"issue":"9","key":"1973_CR16","doi-asserted-by":"publisher","first-page":"2708","DOI":"10.1158\/1078-0432.CCR-18-3729","volume":"25","author":"PE Hall","year":"2019","unstructured":"Hall PE et al (2019) A phase i study of pegylated arginine deiminase (Pegargiminase), cisplatin, and pemetrexed in argininosuccinate synthetase 1-deficient recurrent high-grade glioma. Clin Cancer Res 25(9):2708\u20132716. https:\/\/doi.org\/10.1158\/1078-0432.CCR-18-3729","journal-title":"Clin Cancer Res"},{"key":"1973_CR17","doi-asserted-by":"publisher","first-page":"S129","DOI":"10.1016\/j.semcancer.2015.10.002","volume":"35 Suppl","author":"MD Hirschey","year":"2015","unstructured":"Hirschey MD et al (2015) Dysregulated metabolism contributes to oncogenesis. Semin Cancer Biol 35 Suppl:S129\u2013S150. https:\/\/doi.org\/10.1016\/j.semcancer.2015.10.002","journal-title":"Semin Cancer Biol"},{"key":"1973_CR18","doi-asserted-by":"publisher","first-page":"778","DOI":"10.3389\/fimmu.2018.00778","volume":"9","author":"P Holzmuller","year":"2018","unstructured":"Holzmuller P et al (2018) Trypanosomatid infections: how do parasites and their excreted-secreted factors modulate the inducible metabolism of l-arginine in macrophages? Front Immunol 9:778. https:\/\/doi.org\/10.3389\/fimmu.2018.00778","journal-title":"Front Immunol"},{"key":"1973_CR19","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.938847","volume":"12","author":"X Hou","year":"2022","unstructured":"Hou X et al (2022) Targeted arginine metabolism therapy: a dilemma in glioma treatment. Front Oncol 12:938847. https:\/\/doi.org\/10.3389\/fonc.2022.938847","journal-title":"Front Oncol"},{"issue":"3","key":"1973_CR20","doi-asserted-by":"publisher","first-page":"276","DOI":"10.7150\/ijms.5185","volume":"10","author":"Q Huang","year":"2013","unstructured":"Huang Q et al (2013) Increased co-expression of macrophage migration inhibitory factor and matrix metalloproteinase 9 is associated with tumor recurrence of meningioma. Int J Med Sci 10(3):276\u2013285. https:\/\/doi.org\/10.7150\/ijms.5185","journal-title":"Int J Med Sci"},{"issue":"6122","key":"1973_CR21","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1126\/science.1229259","volume":"339","author":"FW Huang","year":"2013","unstructured":"Huang FW et al (2013) Highly recurrent TERT promoter mutations in human melanoma. Science 339(6122):957\u2013959. https:\/\/doi.org\/10.1126\/science.1229259","journal-title":"Science"},{"issue":"11","key":"1973_CR22","doi-asserted-by":"publisher","first-page":"2505","DOI":"10.1158\/1535-7163.MCT-12-0863","volume":"12","author":"HL Huang","year":"2013","unstructured":"Huang HL et al (2013) Attenuation of argininosuccinate lyase inhibits cancer growth via cyclin A2 and nitric oxide. Mol Cancer Ther 12(11):2505\u20132516. https:\/\/doi.org\/10.1158\/1535-7163.MCT-12-0863","journal-title":"Mol Cancer Ther"},{"issue":"6","key":"1973_CR23","doi-asserted-by":"publisher","first-page":"3131","DOI":"10.3892\/or.2015.4280","volume":"34","author":"HL Huang","year":"2015","unstructured":"Huang HL et al (2015) Argininosuccinate lyase is a potential therapeutic target in breast cancer. Oncol Rep 34(6):3131\u20133139. https:\/\/doi.org\/10.3892\/or.2015.4280","journal-title":"Oncol Rep"},{"issue":"9","key":"1973_CR24","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1046\/j.1432-1033.2003.03559.x","volume":"270","author":"A Husson","year":"2003","unstructured":"Husson A et al (2003) Argininosuccinate synthetase from the urea cycle to the citrulline-NO cycle. Eur J Biochem 270(9):1887\u201399. https:\/\/doi.org\/10.1046\/j.1432-1033.2003.03559.x","journal-title":"Eur J Biochem"},{"issue":"6","key":"1973_CR25","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.3171\/2012.8.JNS12393","volume":"117","author":"T Ius","year":"2012","unstructured":"Ius T et al (2012) Low-grade glioma surgery in eloquent areas: volumetric analysis of extent of resection and its impact on overall survival. A single-institution experience in 190 patients: clinical article. J Neurosurg 117(6):1039\u20131052. https:\/\/doi.org\/10.3171\/2012.8.JNS12393","journal-title":"J Neurosurg"},{"issue":"8","key":"1973_CR26","doi-asserted-by":"publisher","first-page":"033332","DOI":"10.1242\/dmm.033332","volume":"11","author":"R Keshet","year":"2018","unstructured":"Keshet R, Erez A (2018) Arginine and the metabolic regulation of nitric oxide synthesis in cancer. Dis Model Mech 11(8):033332. https:\/\/doi.org\/10.1242\/dmm.033332","journal-title":"Dis Model Mech"},{"issue":"1","key":"1973_CR27","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s40170-021-00271-8","volume":"9","author":"S Khare","year":"2021","unstructured":"Khare S et al (2021) ASS1 and ASL suppress growth in clear cell renal cell carcinoma via altered nitrogen metabolism. Cancer Metab 9(1):40. https:\/\/doi.org\/10.1186\/s40170-021-00271-8","journal-title":"Cancer Metab"},{"key":"1973_CR28","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.168475","author":"J Kho","year":"2023","unstructured":"Kho J et al (2023) Argininosuccinate lyase deficiency causes blood-brain barrier disruption via nitric oxide-mediated dysregulation of claudin expression. JCI Insight. https:\/\/doi.org\/10.1172\/jci.insight.168475","journal-title":"JCI Insight"},{"issue":"2","key":"1973_CR29","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1227\/01.neu.0000316018.51292.19","volume":"62","author":"K Kobayashi","year":"2008","unstructured":"Kobayashi K et al (2008) Enhanced tumor growth elicited by L-type amino acid transporter 1 in human malignant glioma cells. Neurosurgery 62(2):493\u2013503. https:\/\/doi.org\/10.1227\/01.neu.0000316018.51292.19","journal-title":"Neurosurgery"},{"issue":"2","key":"1973_CR30","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1007\/s00394-012-0353-1","volume":"52","author":"S Lechowski","year":"2013","unstructured":"Lechowski S et al (2013) Combined arginine and glutamine decrease release of de novo synthesized leukotrienes and expression of proinflammatory cytokines in activated human intestinal mast cells. Eur J Nutr 52(2):505\u201312. https:\/\/doi.org\/10.1007\/s00394-012-0353-1","journal-title":"Eur J Nutr"},{"issue":"8","key":"1973_CR31","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","volume":"23","author":"DN Louis","year":"2021","unstructured":"Louis DN et al (2021) The 2021 WHO classification of tumors of the central nervous system: a summary. Neuro Oncol 23(8):1231\u20131251. https:\/\/doi.org\/10.1093\/neuonc\/noab106","journal-title":"Neuro Oncol"},{"issue":"5","key":"1973_CR32","doi-asserted-by":"publisher","first-page":"110 e5","DOI":"10.1016\/j.celrep.2018.06.110","volume":"24","author":"I Miller","year":"2018","unstructured":"Miller I et al (2018) Ki67 is a graded rather than a binary marker of proliferation versus quiescence. Cell Rep 24(5):110 e5-11125. https:\/\/doi.org\/10.1016\/j.celrep.2018.06.110","journal-title":"Cell Rep"},{"issue":"2","key":"1973_CR33","doi-asserted-by":"publisher","first-page":"395","DOI":"10.3390\/cancers15020395","volume":"15","author":"R Mora Barthelmess","year":"2023","unstructured":"Mora Barthelmess R, Stijlemans B, Van Ginderachter JA (2023) Hallmarks of cancer affected by the MIF cytokine family. Cancers (Basel) 15(2):395. https:\/\/doi.org\/10.3390\/cancers15020395","journal-title":"Cancers (Basel)"},{"issue":"1","key":"1973_CR34","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1186\/s12885-018-4040-3","volume":"18","author":"L Moren","year":"2018","unstructured":"Moren L et al (2018) Metabolomic profiling identifies distinct phenotypes for ASS1 positive and negative GBM. BMC Cancer 18(1):167. https:\/\/doi.org\/10.1186\/s12885-018-4040-3","journal-title":"BMC Cancer"},{"key":"1973_CR35","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1146\/annurev.nutr.22.110801.140547","volume":"22","author":"SM Morris Jr","year":"2002","unstructured":"Morris SM Jr (2002) Regulation of enzymes of the urea cycle and arginine metabolism. Annu Rev Nutr 22:87\u2013105. https:\/\/doi.org\/10.1146\/annurev.nutr.22.110801.140547","journal-title":"Annu Rev Nutr"},{"issue":"suppl_4","key":"1973_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/neuonc\/noy131","volume":"20","author":"QT Ostrom","year":"2018","unstructured":"Ostrom QT et al (2018) CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2011\u20132015. Neuro Oncol 20(suppl_4):1\u201386. https:\/\/doi.org\/10.1093\/neuonc\/noy131","journal-title":"Neuro Oncol"},{"issue":"1","key":"1973_CR37","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3390\/brainsci8010015","volume":"8","author":"M Paolillo","year":"2018","unstructured":"Paolillo M, Boselli C, Schinelli S (2018) Glioblastoma under Siege: an overview of current therapeutic strategies. Brain Sci 8(1):15. https:\/\/doi.org\/10.3390\/brainsci8010015","journal-title":"Brain Sci"},{"issue":"7578","key":"1973_CR38","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/nature15529","volume":"527","author":"S Rabinovich","year":"2015","unstructured":"Rabinovich S et al (2015) Diversion of aspartate in ASS1-deficient tumours fosters de novo pyrimidine synthesis. Nature 527(7578):379\u2013383. https:\/\/doi.org\/10.1038\/nature15529","journal-title":"Nature"},{"issue":"15 Pt 1","key":"1973_CR39","doi-asserted-by":"publisher","first-page":"4345","DOI":"10.1158\/1078-0432.CCR-07-0472","volume":"13","author":"L Strauss","year":"2007","unstructured":"Strauss L et al (2007) A unique subset of CD4+CD25highFoxp3+ T cells secreting interleukin-10 and transforming growth factor-beta1 mediates suppression in the tumor microenvironment. Clin Cancer Res 13(15 Pt 1):4345\u201354. https:\/\/doi.org\/10.1158\/1078-0432.CCR-07-0472","journal-title":"Clin Cancer Res"},{"issue":"21","key":"1973_CR40","doi-asserted-by":"publisher","first-page":"6301","DOI":"10.1158\/1078-0432.CCR-07-1403","volume":"13","author":"L Strauss","year":"2007","unstructured":"Strauss L et al (2007) The frequency and suppressor function of CD4+CD25highFoxp3+ T cells in the circulation of patients with squamous cell carcinoma of the head and neck. Clin Cancer Res 13(21):6301\u201311. https:\/\/doi.org\/10.1158\/1078-0432.CCR-07-1403","journal-title":"Clin Cancer Res"},{"issue":"10","key":"1973_CR41","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1056\/NEJMoa043330","volume":"352","author":"R Stupp","year":"2005","unstructured":"Stupp R et al (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352(10):987\u201396. https:\/\/doi.org\/10.1056\/NEJMoa043330","journal-title":"N Engl J Med"},{"issue":"43","key":"1973_CR42","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian A et al (2005) Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A 102(43):15545\u201315550. https:\/\/doi.org\/10.1073\/pnas.0506580102","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"1973_CR43","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1038\/s41388-023-02906-0","volume":"43","author":"W Sun","year":"2024","unstructured":"Sun W et al (2024) FOXO3a-regulated arginine metabolic plasticity adaptively promotes esophageal cancer proliferation and metastasis. Oncogene 43(3):216\u2013223. https:\/\/doi.org\/10.1038\/s41388-023-02906-0","journal-title":"Oncogene"},{"issue":"1","key":"1973_CR44","doi-asserted-by":"publisher","first-page":"e458","DOI":"10.1038\/cddis.2012.197","volume":"4","author":"N Syed","year":"2013","unstructured":"Syed N et al (2013) Epigenetic status of argininosuccinate synthetase and argininosuccinate lyase modulates autophagy and cell death in glioblastoma. Cell Death Dis 4(1):e458. https:\/\/doi.org\/10.1038\/cddis.2012.197","journal-title":"Cell Death Dis"},{"issue":"9","key":"1973_CR45","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1016\/S1470-2045(14)70314-6","volume":"15","author":"W Taal","year":"2014","unstructured":"Taal W et al (2014) Single-agent bevacizumab or lomustine versus a combination of bevacizumab plus lomustine in patients with recurrent glioblastoma (BELOB trial): a randomised controlled phase 2 trial. Lancet Oncol 15(9):943\u2013953. https:\/\/doi.org\/10.1016\/S1470-2045(14)70314-6","journal-title":"Lancet Oncol"},{"issue":"4","key":"1973_CR46","doi-asserted-by":"publisher","first-page":"299","DOI":"10.3322\/caac.21613","volume":"70","author":"AC Tan","year":"2020","unstructured":"Tan AC et al (2020) Management of glioblastoma: State of the art and future directions. CA Cancer J Clin 70(4):299\u2013312. https:\/\/doi.org\/10.3322\/caac.21613","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"1973_CR47","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-23264-z","volume":"12","author":"Y Wang","year":"2021","unstructured":"Wang Y et al (2021) MIF is a 3\u2019 flap nuclease that facilitates DNA replication and promotes tumor growth. Nat Commun 12(1):2954. https:\/\/doi.org\/10.1038\/s41467-021-23264-z","journal-title":"Nat Commun"},{"issue":"5","key":"1973_CR48","doi-asserted-by":"publisher","first-page":"106692","DOI":"10.1016\/j.isci.2023.106692","volume":"26","author":"D Wang","year":"2023","unstructured":"Wang D et al (2023) Single-cell transcriptomics reveals heterogeneity and intercellular crosstalk in human intervertebral disc degeneration. iScience 26(5):106692. https:\/\/doi.org\/10.1016\/j.isci.2023.106692","journal-title":"iScience"},{"issue":"1","key":"1973_CR49","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-22105-z","volume":"15","author":"S Wang","year":"2025","unstructured":"Wang S et al (2025) Screening of targets related to amino acid metabolism in glioma to identify the tumor-promoting effects of its core gene ASL. Sci Rep 15(1):38161. https:\/\/doi.org\/10.1038\/s41598-025-22105-z","journal-title":"Sci Rep"},{"issue":"45","key":"1973_CR50","doi-asserted-by":"publisher","first-page":"5904","DOI":"10.1038\/onc.2008.271","volume":"27","author":"TL Whiteside","year":"2008","unstructured":"Whiteside TL (2008) The tumor microenvironment and its role in promoting tumor growth. Oncogene 27(45):5904\u201312. https:\/\/doi.org\/10.1038\/onc.2008.271","journal-title":"Oncogene"},{"issue":"22","key":"1973_CR51","doi-asserted-by":"publisher","first-page":"4452","DOI":"10.1111\/bph.15622","volume":"178","author":"TH Wirtz","year":"2021","unstructured":"Wirtz TH et al (2021) Macrophage migration inhibitory factor exerts pro-proliferative and anti-apoptotic effects via CD74 in murine hepatocellular carcinoma. Br J Pharmacol 178(22):4452\u20134467. https:\/\/doi.org\/10.1111\/bph.15622","journal-title":"Br J Pharmacol"},{"issue":"10","key":"1973_CR52","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.2741\/4573","volume":"22","author":"SY Wu","year":"2017","unstructured":"Wu SY, Watabe K (2017) The roles of microglia\/macrophages in tumor progression of brain cancer and metastatic disease. Front Biosci (Landmark Ed) 22(10):1805\u20131829. https:\/\/doi.org\/10.2741\/4573","journal-title":"Front Biosci (Landmark Ed)"},{"issue":"4","key":"1973_CR53","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.it.2021.02.004","volume":"42","author":"W Xuan","year":"2021","unstructured":"Xuan W et al (2021) Context-dependent glioblastoma-macrophage\/microglia symbiosis and associated mechanisms. Trends Immunol 42(4):280\u2013292. https:\/\/doi.org\/10.1016\/j.it.2021.02.004","journal-title":"Trends Immunol"},{"issue":"10","key":"1973_CR54","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1038\/nri1936","volume":"6","author":"L Zitvogel","year":"2006","unstructured":"Zitvogel L, Tesniere A, Kroemer G (2006) Cancer despite immunosurveillance: immunoselection and immunosubversion. Nat Rev Immunol 6(10):715\u201327. https:\/\/doi.org\/10.1038\/nri1936","journal-title":"Nat Rev Immunol"}],"container-title":["Functional & Integrative Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10142-026-01973-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10142-026-01973-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10142-026-01973-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T02:43:04Z","timestamp":1783564984000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10142-026-01973-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,9]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["1973"],"URL":"https:\/\/doi.org\/10.1007\/s10142-026-01973-2","relation":{},"ISSN":["1438-793X","1438-7948"],"issn-type":[{"value":"1438-793X","type":"print"},{"value":"1438-7948","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,9]]},"assertion":[{"value":"12 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"The authors declared no competing interest.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}}],"article-number":"184"}}